An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 81: CYP2C9 (10q23.33)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs1934963 X-11787 T/C 7362 0.8 0.029 (0.002) 8.69·10-65 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs1934963
Chromosomal locationChr10: 96,724,666 (10q23.33)
Gene (distance)CYP2C9 (0)
Predicted causal geneunknown
Gene/protein classificationmetabolic enzyme
Metabolite (Pathway)X-11787 (Unknown)
Biochemical locus-metabolite relationshipX-11787 is an unknown metabolite
eQTL associations-

 

Medical information
Complex trait associationsWarfarin maintenance dose [18535201]
Known metabolite associationsX-11787 [23093944] (r2=0.308 with rs7896133)
Inborn error of metabolism-

Pharmacological information
ChEMBL IDCHEMBL3397
Drug information Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map